NCT00006023 2019-06-26
Capecitabine in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Swiss Cancer Institute
Phase 2 Completed
Clinical Trials
4 trialsNCT00124566 2016-01-18
Study of Irofulven in Patients With Hormone-refractory Prostate Cancer
Eisai Inc.
Phase 2 Completed
NCT00151047 2015-01-21
Docetaxel Plus Capecitabine in Newly Diagnosed Localized or Locally Advanced Prostate Cancer
University of Michigan Rogel Cancer Center
Phase 2 Completed
NCT00258284 2014-03-06
Capecitabine and Docetaxel in Treating Patients With Metastatic Prostate Cancer
Barbara Ann Karmanos Cancer Institute
Phase 2 Completed